Compare LNTH & TPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LNTH | TPH |
|---|---|---|
| Founded | 1956 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.0B |
| IPO Year | 2014 | 2012 |
| Metric | LNTH | TPH |
|---|---|---|
| Price | $76.10 | $46.75 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 6 |
| Target Price | ★ $83.20 | $42.50 |
| AVG Volume (30 Days) | 958.1K | ★ 2.8M |
| Earning Date | 05-06-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 3.41 | 2.72 |
| Revenue | $343,374,000.00 | ★ $3,260,447,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.93 | $10.20 |
| P/E Ratio | $22.31 | ★ $17.18 |
| Revenue Growth | 3.62 | ★ 5.76 |
| 52 Week Low | $47.27 | $27.90 |
| 52 Week High | $108.86 | $46.76 |
| Indicator | LNTH | TPH |
|---|---|---|
| Relative Strength Index (RSI) | 51.22 | 76.68 |
| Support Level | $72.33 | $46.24 |
| Resistance Level | $84.77 | $46.76 |
| Average True Range (ATR) | 2.47 | 0.11 |
| MACD | -0.58 | -0.31 |
| Stochastic Oscillator | 40.96 | 97.83 |
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
Tri Pointe Homes Inc is an American construction company that focuses on residential construction. The company is engaged in the design, construction, and sale of single-family attached and detached homes in different states across the United States. Its operations are organized into two principal businesses: homebuilding. which generates key revenue, and financial services. The homebuilding business has three reportable operating segments, based on the geographical layout of the markets, and includes West region, Central region, and East region. Its financial services operation is comprised of its Tri Pointe Connect mortgage financing operations, Tri Pointe Assurance title and escrow services operations, and Tri Pointe Advantage property and casualty insurance agency operations.